Atıf Formatları
EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS WITH CHRONIC HEMODIALYSIS AND KIDNEY TRANSPLANTATION‐ REALITY STUDY
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. Yapalı, "EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS WITH CHRONIC HEMODIALYSIS AND KIDNEY TRANSPLANTATION‐ REALITY STUDY," AASLD-TASL Hepatology Connect , pp.1-2, 2021

Yapalı, S. 2021. EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS WITH CHRONIC HEMODIALYSIS AND KIDNEY TRANSPLANTATION‐ REALITY STUDY. AASLD-TASL Hepatology Connect , 1-2.

Yapalı, S., (2021). EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS WITH CHRONIC HEMODIALYSIS AND KIDNEY TRANSPLANTATION‐ REALITY STUDY . AASLD-TASL Hepatology Connect (pp.1-2).

Yapalı, Suna. "EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS WITH CHRONIC HEMODIALYSIS AND KIDNEY TRANSPLANTATION‐ REALITY STUDY," AASLD-TASL Hepatology Connect, 2021

Yapalı, Suna. "EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS WITH CHRONIC HEMODIALYSIS AND KIDNEY TRANSPLANTATION‐ REALITY STUDY." AASLD-TASL Hepatology Connect , pp.1-2, 2021

Yapalı, S. (2021) . "EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS WITH CHRONIC HEMODIALYSIS AND KIDNEY TRANSPLANTATION‐ REALITY STUDY." AASLD-TASL Hepatology Connect , pp.1-2.

@conferencepaper{conferencepaper, author={Suna YAPALI}, title={EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS WITH CHRONIC HEMODIALYSIS AND KIDNEY TRANSPLANTATION‐ REALITY STUDY}, congress name={AASLD-TASL Hepatology Connect}, city={}, country={}, year={2021}, pages={1-2} }